---
$id: https://graph.org.ai/products/commodity/51111707
$type: Product
source: UNSPSC
code: "51111707"
title: "Deoxycoformycin or pentostatin"
class: "51111700"
classTitle: "Antineoplastic antibiotics"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Deoxycoformycin or pentostatin

**UNSPSC Code**: 51111707
**Class**: [Antineoplastic antibiotics](Antineoplastic antibiotics.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an adenosine deaminase inhibitor with the molecular formula C11H16N4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 395575MZO7, chemically known as (r)-3-(2-deoxy-beta-d-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo(4,5-d)(1,3)diazepin-8-ol but generally known as pentostatin, which bears US NIH Compound Identifier 40926. European Medicines Agency schedules Pentostatin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09704MIG. The term PENTOSTATIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). World Health Organization schedules pentostatin in its Anatomical Therapeutic Chemical (ATC) Classification. PENTOSTATIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Deoxycoformycin or pentostatin bears US NLM identifiers UMLS ID C0030896 and NCI Concept Code C732. SMILES: C1C(C(OC1N2C=NC3=C2NC=NCC3O)CO)O.

